If you're a woman starting a GLP-1 medication, you probably have questions that go beyond the number on the scale. Will your periods change? Could this affect your birth control? What if you want to get pregnant someday? These are some of the most common (and most important) questions we hear in our practice, and they deserve clear, careful answers rather than headlines. Here's what the evidence actually says, and how we think about it in a physician-led program.

GLP-1 and women's health: the short version

GLP-1 medications were designed to manage type 2 diabetes and obesity, but their effects ripple into reproductive health in ways that matter for women of childbearing age. Three things are worth understanding up front: weight loss can change your menstrual cycle, it can affect fertility, and certain GLP-1 medications may interact with the birth control pill. None of this should scare you off treatment: it just means these are conversations to have with your prescriber, not afterthoughts.

This article is educational and isn't a substitute for personalized medical advice. Our program is physician-led by Dr. Tran Le, MD, who is board-certified in Obesity Medicine, so these reproductive considerations are part of how we counsel patients from the first visit.

How GLP-1 medications can change your periods

Excess weight and insulin resistance disrupt the hormonal signaling that drives a regular cycle. Obese women undergo perturbations of the hypothalamic-pituitary-ovarian axis, and frequently suffer menstrual dysfunction leading to anovulation and infertility. In adult women, most studies report a prevalence of menstrual cycle irregularities in women with obesity of 30% to 36%.

The encouraging part is that this can improve. Weight loss programs through lifestyle modification in obese women have been proven to restore menstrual cyclicity and ovulation and improve the likelihood of conception. Professional guidance reflects this too: the American Society for Reproductive Medicine notes that improved ovulation rates and menstrual regularity have been demonstrated with modest weight loss through lifestyle modification, with and without adjunctive weight loss medications, in women with PCOS.

In practical terms, that means some women notice their cycles becoming more regular, or returning after a long absence, as they lose weight on a GLP-1. In our practice, patients sometimes mention period changes before they mention anything else: it's a real and expected part of metabolic improvement.

GLP-1 medications, PCOS, and fertility

Polycystic ovary syndrome is the most common hormonal disorder in reproductive-age women and a leading cause of ovulatory infertility. Because insulin resistance and weight sit at the center of PCOS, GLP-1 therapy is being studied closely here. A scoping review found that GLP-1 receptor agonist use demonstrated promising clinical outcomes for women with PCOS, including reduced BMI, improved metabolic parameters, menstrual regularity, and increased rates of natural pregnancy.

A broader review of the evidence concluded that fertility outcomes may improve with GLP-1RAs and dual GLP-1/GIP agonists due to weight loss and related metabolic benefits. How much weight loss matters? For PCOS, the literature has long pointed to a modest threshold: although the optimal degree of weight loss to restore ovulatory function is not clear, at least 5 to 10% weight loss is generally recommended.

This is the mechanism behind the so-called "Ozempic babies" stories. GLP-1 medications aren't fertility drugs, but by improving weight, insulin sensitivity, and ovulation, they can make pregnancy more likely in women who previously struggled to conceive. The research base is still growing, and much of it focuses specifically on women with PCOS, so we counsel patients with that honesty rather than overpromising.

We cover the medication options we prescribe (including compounded semaglutide and tirzepatide) in more detail elsewhere on our site.

The birth control question every woman should ask

Here's the part that surprises people. GLP-1 medications can affect how the oral contraceptive pill works, but not all of them, and not in the same way.

The key is the mechanism. GLP-1 medicines cause the stomach to empty more slowly, supporting weight loss by making people feel fuller, longer. The downside is that oral medications are released into the body with the same delay. The published evidence shows this matters most for one drug class: while tirzepatide has been shown to impact absorption of oral contraceptives due to delayed gastric emptying, other GLP-1 receptor agonists do not appear to have clinically significant interactions with oral contraception.

Because of this, the manufacturer of tirzepatide advises a specific precaution. Due to risks for decreased bioavailability of birth control pills, the manufacturer of Mounjaro (tirzepatide) recommends that patients either use barrier contraception for four weeks after initiation or after a dose increase, or switch to a non-oral contraceptive. There's also a practical wrinkle: the effect on birth control pills is most pronounced during dose adjustments, and occasional nausea and vomiting triggered as a side effect of these medications may also cause a woman to lose a dose without realizing it.

The reassuring news is that non-oral methods aren't affected. Non-oral contraceptives (like the IUD, implant, patch, or condoms) do not appear to be affected by GLP-1 use. If pregnancy isn't your goal right now, this is exactly the kind of thing to raise at your consult so we can build a plan that fits you. You can read more about our medication choices on our tirzepatide and semaglutide pages.

Planning a pregnancy on a GLP-1

GLP-1 medications are not used during pregnancy. For semaglutide, the FDA-approved labeling is explicit: providers should discontinue semaglutide in women at least 2 months before a planned pregnancy due to the long washout period for semaglutide. That timing exists because the drug clears slowly: semaglutide is dosed weekly because of its roughly one-week half-life, so it lingers for weeks after a final dose.

If you become pregnant unexpectedly while on a GLP-1, don't panic, but do act. Stop the medication and contact your OB-GYN and your prescriber promptly. Because GLP-1 therapy can quietly improve fertility, an unplanned pregnancy is a genuine possibility, which is one more reason the birth control conversation matters.

A note on compounded medications: compounded semaglutide and tirzepatide are not FDA-approved, and the same pregnancy precautions and clinical caution apply. We walk through all of this in how it works.

Frequently asked questions

Will a GLP-1 make my periods regular again?

It might. Weight loss has been shown to restore menstrual regularity and ovulation in many women, especially those with obesity or PCOS. Everyone's body is different, so we monitor your response individually rather than promising a specific outcome.

Does my birth control pill still work on a GLP-1?

It depends on the medication. The strongest evidence for reduced pill absorption is with tirzepatide, where backup contraception is advised when starting and after dose increases. Non-oral methods like IUDs, implants, the patch, and condoms aren't affected. Talk with your prescriber about what fits you.

Can I take a GLP-1 if I'm trying to get pregnant?

No. Semaglutide labeling recommends stopping at least two months before a planned pregnancy, and the medication isn't used during pregnancy. If conception is on your horizon, we'll help you plan the timing of your last dose.

Talk it through with a physician-led team

Women's health questions deserve more than a quick label scan. Our Texas and Utah telehealth program is led by Dr. Le, and we build these reproductive considerations (periods, contraception, and pregnancy planning) into your care from the start. If you're weighing your options, start a consultation and let's make a plan that fits your body and your goals. You can also review our pricing to see what's included.

GLP-1 and Women's Health: Periods, Fertility & Birth Control